drugset / Trial / NCT00208741

Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder

NCT00208741

Phase 4 Completed 50 enrolled Emory University Cephalon · collab
RandomizedSingle-groupDouble-blindTreatment

Summary

The main purpose of this study is to determine how safe and effective Gabitril is for outpatients with Social Anxiety Disorder (SAD).

Timeline

Start
2002-06
Primary completion
Completion
2003-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Tiagabine Small molecule

Indications